• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • UK / Ireland

Northstar’s Applied Graphene raises £11m in IPO

  • Ellie Pullen
  • 20 November 2013
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Northstar Ventures-backed Applied Graphene Materials (AGM) has raised £11m in its flotation on the AIM, giving the company a market cap of £26.2m.

Shares started trading at 8am (GMT) this morning. The firm offered 7.1 million ordinary shares at a price of £1.55 per unit in its IPO. Of the £11m raised, net proceeds going to AGM will amount to approximately £9.9m.

AGM is backed by the £15m North East Proof of Concept Fund (POCF), which is managed by Northstar Ventures, and the £25m North East Technology Fund (NETF), managed by IP Group.

Applied Graphene Materials

  • DEAL:

    IPO

  • VALUE:

    £26.2m (market cap)

  • LOCATION:

    Teesside

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    2010

POCF holds a 10.4% stake in AGM, worth £2.73m at the company's initial trading price, while NETF owns 14.5% of AGM's shareholding, worth £3.78m. IP Group, the fund manager for NETF, also holds a direct 20.4% stake in AGM.

POCF and NETF committed £350,000 and £480,000 to the placing respectively, while IP Group committed £2m.

N+1 Singer was appointed as nominated adviser and broker for AGM. The company now trades on the AIM under the ticker symbol "AGM". At the time of writing, shares were trading at around £2.05 apiece.

Previous funding
Alongside IP Group, the two funds invested £1.2m in AGM in February last year. POCF committed £200,000 to the company, while NETF and IP Group split the remainder evenly.

Company
AGM span out of Durham University in 2010 and is now based in Teesside. The company has developed a process for the production of high-purity graphene nanoplatelets based on the use of sustainable raw materials. This means AGM does not have to rely on the supply of graphite for its graphene production process.

Graphene, which was isolated in 2004 by scientists at Manchester University, is a crystalline form of carbon. Due to its strength and light weight, as well as its conductive properties for electricity and heat, the material is currently being tested for various potential applications such as durable display screens, integrated circuits and solar cells.

The company's ultimate goal is to become a supplier of graphene-based speciality chemical products catering to businesses that are manufacturing products containing graphene.

People
Jon Mabbitt is the CEO of AGM.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • UK / Ireland
  • Industrials
  • Exits
  • United Kingdom
  • IPO
  • AIM

More on UK / Ireland

Fund closes in US dollars
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • Funds
  • 05 September 2023
Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013